1. Home
  2. KEQU vs CDXS Comparison

KEQU vs CDXS Comparison

Compare KEQU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$39.07

Market Cap

124.6M

Sector

Industrials

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.68

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
CDXS
Founded
1906
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
KEQU
CDXS
Price
$39.07
$1.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
1.0M
Earning Date
12-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
$52,932,000.00
Revenue This Year
N/A
$15.64
Revenue Next Year
N/A
$5.23
P/E Ratio
$9.59
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$1.52
52 Week High
$71.33
$6.01

Technical Indicators

Market Signals
Indicator
KEQU
CDXS
Relative Strength Index (RSI) 47.32 41.38
Support Level $37.50 $1.62
Resistance Level $41.04 $1.95
Average True Range (ATR) 1.44 0.09
MACD 0.22 0.02
Stochastic Oscillator 51.45 19.12

Price Performance

Historical Comparison
KEQU
CDXS

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: